At Hawaiian Eye, Wendy W. Lee, MD, discusses the diagnosis and management of benign and malignant eye lid lesions.
Author: Healio ophthalmology
Clearside’s triamcinolone acetonide formulation achieves primary endpoint in phase 2 clinical trial
Clearside Biomedical reported in a press release that its triamcinolone acetonide formulation candidate Zuprata achieved its primary endpoint of reducing the need for Eylea retreatments in patients with macular edema associated with retinal vein occlus…
Risk of dissociation with Retisert implant increases over time
The risk for Retisert implant dissociation increases the longer the implant is in the eye, according to a study.Follow-up data of 250 first implants with Retisert (fluocinolone acetonide, Bausch + Lomb) were culled from the Multicenter Uveitis Steroid …
Publication Exclusive: Advances in regenerative medicine may alter treatment of corneal endothelial diseases
The last decade has seen significant advances in the field of corneal surgery. Various lamellar keratoplasty techniques have been refined, and endothelial keratoplasty in the form of Descemet’s stripping automated endothelial keratoplasty has now become the standard for endothelial diseases. Worldwide, DSAEK is now one of the most common techniques for endothelial transplant, with excellent functional outcomes.However, Descemet’s membrane endothelial keratoplasty, with its better functional results and faster visual recovery, is now challenging DSAEK. The concern with DMEK is the handling of the delicate Descemet’s membrane and endothelium and the (Read more...)
Publication Exclusive: Advances in regenerative medicine may alter treatment of corneal endothelial diseases
The last decade has seen significant advances in the field of corneal surgery. Various lamellar keratoplasty techniques have been refined, and endothelial keratoplasty in the form of Descemet’s stripping automated endothelial keratoplasty has now become the standard for endothelial diseases. Worldwide, DSAEK is now one of the most common techniques for endothelial transplant, with excellent functional outcomes.However, Descemet’s membrane endothelial keratoplasty, with its better functional results and faster visual recovery, is now challenging DSAEK. The concern with DMEK is the handling of the delicate Descemet’s membrane and endothelium and the (Read more...)
Interview: Avedro executives discuss FDA approval of cross-linking system
Healio/OSN : The ophthalmology community in the U.S. has been waiting for this approval for quite a while. Can you put this into perspective for ophthalmologists and discuss the importance of this particular approval?
VIDEO: Principles of OCT angiography
At Retina 2016, Jay S. Duker, MD, discusses the basic principles of OCT angiography.
CRYSTAL study shows good results of personalized anti-VEGF treatment regimen in CRVO
Two-year results of the CRYSTAL study show that an as-needed medication regimen with frequent monitoring can reduce the number of anti-VEGF injections needed to achieve and maintain good anatomic and visual acuity outcomes in central retinal vein occlusion.According to Michael Larsen, MD, DMSc, member of the CRYSTAL Study Group, “The criteria of the CRYSTAL regimen can be easily transferred into clinical practice.”
Novartis reports $11.6 billion in net sales in first quarter
Novartis reported $11.6 billion in net sales in the first quarter compared with $11.9 billion in the same quarter of 2015, according to a press release. Net income was reported at $2 billion in the first quarter compared with $2.3 billion reported in t…
Valeant names Joseph C. Papa as new chairman, CEO
Valeant Pharmaceuticals International announced in a press release that its board of directors has named Joseph C. Papa as Valeant’s chairman and CEO.Papa, chairman and CEO of Perrigo Company plc, a global health care supplier that develops and distributes over-the-counter and prescription pharmaceuticals, is expected to begin his new position in early May, according to the release. He will succeed J. Michael Pearson, who is expected to remain as CEO and a director until Papa begins at Valeant, the release reported.
Rituximab used to treat recalcitrant noninfectious scleritis
Rituximab, with and without additional immunomodulatory therapy, resulted in steroid-free remission of recalcitrant noninfectious scleritis in a majority of patients in one study. The retrospective case series included 24 eyes of 15 patients with clini…
VIDEO: Oculoplastic anatomy 101 — Eyelid, lacrimal system and orbit
At Hawaiian Eye, Jeremiah Tao, MD, FACS, gives a case-based presentation on surgical procedures for areas in the eyelid, lacrimal system and orbit.
VIDEO: New developments in widefield imaging
At Retina 2016, SriniVas Sadda, MD, discusses the advances and recent developments of widefield imaging.
VIDEO: Bulletproof blepharoplasty
At Hawaiian Eye, Andrew R. Harrison, MD, shares pearls on how to perform blepharoplasty and achieve positive aesthetic results and no complications, as well as maintaining patient satisfaction.
Abbott reports $4.9 billion in worldwide sales in first quarter
Abbott reported $4.9 billion in worldwide sales in the first quarter, a 5.1% increase on an operational basis and a 0.2% decrease on a reported basis compared with the previous year, according to a press release. U.S. sales increased 1.9%, partly becau…
VIDEO: Pearls for using neuromodulators and toxins in the ophthalmic practice
At Hawaiian Eye, Steve G. Yoelin, MD, shares pearls for using neuromodulators and toxins in the ophthalmic practice.
Bilateral, contralateral multifocal IOLs yield similar intermediate, distance visual acuity
Bilateral implantation of a multifocal IOL was non-inferior to contralateral implantation of different multifocal IOLs in terms of intermediate and distance visual acuity, according to a study. However, bilateral implantation did not yield comparable near vision.“These results suggest that contralateral implantation might have a higher likelihood than bilateral implantation of patients attaining spectacle independence over a wide range of distances,” the study authors said.
VIDEO: Boston keratoprosthesis in severe external disease
The Boston keratoprosthesis technique may be a good option in the surgical management of severe external disease. In this particular case with severe pemphigoid, almost ankyloblepharon, cornea scarring and dense cataract, we performed a combined symble…
VIDEO: Lights and lasers for the ophthalmologist
At Hawaiian Eye, Roger A. Dailey, MD, FACS, discusses available lights and lasers that ophthalmologists can use in their practice.
Advances in regenerative medicine may alter treatment of corneal endothelial diseases
The last decade has seen significant advances in the field of corneal surgery. Various lamellar keratoplasty techniques have been refined, and endothelial keratoplasty in the form of Descemet’s stripping automated endothelial keratoplasty has now become the standard for endothelial diseases. Worldwide, DSAEK is now one of the most common techniques for endothelial transplant, with excellent functional outcomes.However, Descemet’s membrane endothelial keratoplasty, with its better functional results and faster visual recovery, is now challenging DSAEK. The concern with DMEK is the handling of the delicate Descemet’s membrane and endothelium and the (Read more...)